News about Drug Discovery & Development

AstraZeneca partners with Australia-based LBT Innovations for new pharma product line

AstraZeneca will fund the development of the APAS Pharma analysis module and validate the final product for their processes
<br />

Drug Discovery & Development | 12/01/2023 | By Sudeep Soparkar |  705

Glenmark Pharma launches Bumetanide Injection in single and multi-dose vials

The product is the generic version of Bumex 1 Injection, 0.25 mg/mL, of Validus Pharmaceuticals

Drug Discovery & Development | 11/01/2023 | By Sudeep Soparkar |  733

Zydus launches Topiramate extended-release capsules

Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the US
<br />

Drug Discovery & Development | 07/01/2023 | By Sudeep Soparkar |  700

Asymchem opens R&D site near Boston, Massachusetts

The new Boston site is focussed on providing early-stage R&D services including chemical process development, pre-formulation study and formulation development
<br />

Drug Discovery & Development | 20/12/2022 | By Sudeep Soparkar |  757

Freudenberg Medical unveils HelixFlex at CPhI & PMEC India

TPE tubing is ideal for pharmaceutical bioprocessing applications

Drug Discovery & Development | 30/11/2022 | By Sudeep Soparkar |  735

Cipla unveils Leuprolide Acetate Injection Depot 22.5mg

The injection is indicated for the palliative treatment of advanced prostate cancer

Drug Discovery & Development | 29/11/2022 | By Sudeep Soparkar |  883

NATCO Pharma launches Pomalyst caps in Australia

The product was launched by NATCO’s commercial partner Juno Pharmaceuticals

Drug Discovery & Development | 09/11/2022 | By Sudeep Soparkar |  1051

Glenmark launches Teneligliptin + Dapagliflozin Fixed-Dose Combination for adults with Type 2 diabetes

With this new launch, the company aims to improve glycemic control in adult patients with uncontrolled type 2 diabetes

Drug Discovery & Development | 21/10/2022 | By Sudeep Soparkar |  579

Yapan Bio adds process development facility

Expands capacity and capabilities in large molecule therapeutics

Drug Discovery & Development | 19/10/2022 | By Sudeep Soparkar |  693

Baxter Pharma opens global pharma R&D Centre in Ahmedabad

The 20,500-square-foot, state-of-the-art R&D Centre features an array of sophisticated equipment and research labs that will focus on pharmaceutical product development

Drug Discovery & Development | 18/10/2022 | By Sudeep Soparkar |  2481